American Journal of Neuroradiology 21:375-380 (2 2000)
© 2000 American Society of Neuroradiology
ARTICLE
MR Spectroscopy in Gliomatosis Cerebri
a From the Departments of Neuroradiology (M.B., M.W-M., L.S.), Neuropathology (R.K.), and Neurosurgery (R.B., C.S., J.C.T.), University of Würzburg, Germany.
BACKGROUND AND PURPOSE: The diagnosis of gliomatosis cerebri with MR imaging is known to be difficult. We report on the value of MR spectroscopy in the diagnosis, grading, and biopsy planing in eight patients with histopathologically proved gliomatosis cerebri.
METHODS: Patients underwent MR imaging and MR spectroscopy (single-voxel point-resolved spectroscopy [PRESS] at 1500/135, and chemical-shift imaging [CSI] PRESS at 1500/135) before open (n = 4) or stereotactic (n = 4) biopsy. In six patients who underwent CSI, biopsy samples were taken from regions of maximally elevated levels of choline/N-acetylaspartate (Cho/NAA).
RESULTS: All patients showed elevated Cho/creatine (Cr) and Cho/NAA levels as well as varying degrees of decreased NAA/Cr ratios, which were most pronounced in the anaplastic lesions. In low-grade lesions, there was a maximum Cho/NAA ratio of 1.3, whereas in anaplastic tumors, the maximum Cho/NAA level was at least 2.5. Spectra in two patients with grade III lesions revealed a lactate peak; lactate and lipid signals were seen in two patients with grade IV lesions. Biopsy specimens from regions with maximally elevated levels of Cho/NAA showed dense infiltration of tumor cells.
CONCLUSION: MR spectroscopy might be used to classify gliomatosis cerebri as a stable or a progressive disease indicating its potential therapeutic relevance.
This article has been cited by other articles:
![]() |
R. N. Al-Okaili, J. Krejza, J. H. Woo, R. L. Wolf, D. M. O'Rourke, K. D. Judy, H. Poptani, and E. R. Melhem Intraaxial Brain Masses: MR Imaging-based Diagnostic Strategy--Initial Experience Radiology, May 1, 2007; 243(2): 539 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Guzman-de-Villoria, J. Sanchez-Gonzalez, L. Munoz, S. Reig, C. Benito, P. Garcia-Barreno, and M. Desco 1H MR Spectroscopy in the Assessment of Gliomatosis Cerebri Am. J. Roentgenol., March 1, 2007; 188(3): 710 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Saraf-Lavi, B. C. Bowen, P. M. Pattany, E. M.L. Sklar, J. B. Murdoch, and C. K. Petito Proton MR Spectroscopy of Gliomatosis Cerebri: Case Report of Elevated Myoinositol with Normal Choline Levels AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 946 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Lev Gliomatosis Cerebri has Normal Relative Blood Volume: Really?! Who cares? Should you? AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 345 - 346. [Full Text] [PDF] |
||||
![]() |
S. Yang, S. Wetzel, and S. Cha Dynamic Contrast-Enhanced T2*-Weighted MR Imaging of Gliomatosis Cerebri AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 350 - 355. [Abstract] [Full Text] [PDF] |
||||


